Edenred Shares Jump 2.29% Despite a 40% Drop Over the Year
Edenred's stock price increased by 2.29% this Wednesday, reaching €18.75 in a rising Parisian market. This advance follows a recent de-escalation in geopolitical tensions between Washington and Tehran, contributing to a sharp rebound in the CAC 40 earlier in the week. However, the stock is still down nearly 40% over the year.
Short-Term Trend Reversal Indicated
During the session, Edenred's stock price surpassed its 50-day moving average (€18.17), a threshold it had struggled to exceed in recent weeks. Crossing above this indicator, closely watched by traders to gauge short-term trends, signals a potential bullish reversal after several months of significant decline. The RSI, at 47, remains in a neutral zone, currently indicating neither overbought nor oversold conditions.
The stock price is also moving within the Bollinger Bands, with the lower bound at €17.55 and the upper bound at €19.89. The nearest resistance level, at €19.74, nearly coincides with this upper limit, making it a key level to watch if the upward movement continues. In the broader market context, Edenred's progress reflects a favorable environment for the Parisian market: the CAC 40 is up 1.51% in Wednesday's session, while the SBF 120 has gained 1.54%.
Year-Long Downtrend Persists
Despite today's rebound, Edenred's trajectory over the past twelve months remains significantly degraded, with a decline of 39.88%. The stock has lost over a third of its value since March 2025, while its 200-day moving average, established at €21.50, remains far from the current price. This significant gap illustrates the long-term bearish trend that has prevailed for over a year.
On the financial calendar front, the first quarter revenue announcement is expected on April 23, followed by the annual general meeting scheduled for May 7, 2026. These events could be significant catalysts for the stock, providing visibility into the commercial dynamics of the group specialized in specific-use payment solutions. The monthly volatility, measured at 12.39%, remains moderate, with a very low beta of 0.19, indicating limited sensitivity of the stock to general market fluctuations.